Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Fresenius USA

This article was originally published in The Gray Sheet

Executive Summary

Fresenius USA: Company selects Salomon Brothers Inc. to aid in the assessment and negotiation of economic terms on which FUSA would participate in combining Fresenius AG, FUSA and W.R. Grace's National Medical Care unit into Fresenius Medical Care. Under terms of the definitive agreement, announced Feb. 4, Fresenius AG would purchase 55% of NMC for $2.3 mil. in cash. FUSA is approximately 70% owned by Germany-based Fresenius AG...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel